PAISLEY, United Kingdom--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has completed the acquisition of Prionics AG, a privately held animal health diagnostics company.
Founded in 1997, Prionics is headquartered in Zurich, Switzerland, and has a major production facility in Lelystad, the Netherlands. Prionics’ product line of more than 50 diagnostic test kits, accessories and biochemicals expands the portfolio of animal health testing products under the Life Technologies brand.
“Prionics adds a unique blend of expertise and diagnostic solutions to new and existing customers,” said Kirk Adams, Ph.D., global animal health leader. “Improved accessibility to animal testing benefits both veterinarians and livestock producers.”
“Combining Prionics under the Life Technologies’ brand is certainly a win-win, since the products and capabilities are highly complementary,” said Dr. Markus Moser, CEO of Prionics. “We believe this will have a strong and worldwide impact on the animal health industry.”
Prionics brings a state-of-the-art infrastructure along with a certified tuberculin manufacturing facility, plus additional enzyme-linked immunosorbent assays (ELISA) under the Life Technologies brand.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Our four premier brands – Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services – offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.